Chiesi Farmaceutici SpA

Where the EU money came from

Funding by EU programme. Amounts are Chiesi Farmaceutici SpA's own share of each project, not the project's full budget.

Projects

12 EU-funded projects, newest first. Chiesi Farmaceutici SpA led 3 of them as coordinator. Each links to the official record.

• RADICALLYPartner

  Enantioselective Catalysis for Radical Transformations

  Horizon Europe · 2027–2031 · Project on CORDIS ↗

  €282ktheir share
• eGreenchemCoordinator

  Electrochemical late stage functionalisation of nucleosides via chemo-regioselective C-H activation of C5 position.

  Horizon Europe · 2025–2027 · Project on CORDIS ↗

  €194ktheir share
• READIPartner

  REpresentative Clinical Research - ADvancing Inclusivity in Europe

  Horizon Europe · 2025–2030 · Project on CORDIS ↗
• FutureData4EUAssociated partner

  Training Future Big Data Experts for Europe

  Horizon Europe · 2023–2028 · Project on CORDIS ↗
• EU GREENAssociated partner

  European University alliance for sustainability: responsible GRowth, inclusive Education and ENvironment

  Erasmus+ (ERASMUS+) · 2023–2026 · Project on the EU portal ↗
• PREMSTEMPartner

  Brain injury in the premature born infant: stem cell regeneration research network

  Horizon 2020 · 2020–2025 · Project on CORDIS ↗

  €908ktheir share
• MS4DrugCoordinator

  An Innovative Mass Spectrometry-Based Workflow for Drug Discovery

  Horizon 2020 · 2019–2021 · Project on CORDIS ↗

  €171ktheir share
• FAIR-PARK-IIPartner

  Conservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone

  Horizon 2020 · 2015–2021 · Project on CORDIS ↗
• NEUROINFLAMMATIONPartner

  nEUROinflammation

  FP7 (2007 to 2013) · 2013–2017 · Project on CORDIS ↗

  €241ktheir share
• EUPATIPartner

  European Patients' Academy on Therapeutic Innovation

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
• U-BIOPREDPartner

  Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes

  FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗
• PRO- ACTIVECoordinator

  Physical Activity as a Crucial Patient Reported Outcome in COPD

  FP7 (2007 to 2013) · 2009–2016 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Astrazeneca ABSweden · 4 shared projects
• Novartis Pharma AGSwitzerland · 4 shared projects
• Glaxosmithkline Research & Development LimitedUnited Kingdom · 4 shared projects
• Boehringer Ingelheim InternationalgmbhGermany · 4 shared projects
• Pfizer LimitedUnited Kingdom · 4 shared projects
• Kobenhavns UniversitetDenmark · 3 shared projects
• Stichting Radboud UniversiteitNetherlands · 3 shared projects
• The University of ManchesterUnited Kingdom · 3 shared projects
• Universitaet BernSwitzerland · 3 shared projects
• F. Hoffmann-La Roche AGSwitzerland · 3 shared projects
• Almirall SASpain · 3 shared projects
• AmgenBelgium · 3 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 2 shared projects
• Katholieke Universiteit LeuvenBelgium · 2 shared projects
• Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 2 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• RNA
• agriculture
• asthma
• big data
• bioeconomy
• climatic changes
• coronaviruses
• databases
• drug discovery
• ecosystems
• electrocatalysis
• electrochemistry
• entrepreneurship